OneOme’s RightMed pharmacogenomic test, co-developed by Mayo Clinic, helps pharmacists to guide optimal drug selection and dosing by using a patient’s DNA to predict how they may respond to more than 340 medications. The RightMed test includes a report detailing the results, as well as the RightMed Advisor, an interactive tool to help pharmacists interpret the test results, explore more information about the drugs in the OneOme database, and evaluate drug-to-drug interactions.